• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

insulin

Virta Adds Prediabetes and Obesity Reversal to Services

by Jasmine Pennic 10/07/2020 Leave a Comment

Virta Expands Offerings to Treat New Group of Chronic Illnesses

What You Should Know: - Virta is expanding its suite of treatment options to include prediabetes reversal, obesity reversal, and type 2 diabetes management. - By making this crucial expansion, Virta can scale its treatment to support the tens of millions of additional patients with prediabetes and obesity, as provide an on-ramp to reversal for those with T2D that aren’t yet ready to reverse.  Virta Health, the leader in type 2 diabetes reversal, today introduced the addition
Read More

Is Glucometrics The Missing Data in the Fight Against COVID-19?

by Jordan Messler, MD, SFHM, FACP, Executive Director, Clinical Practice, Glytec 09/29/2020 Leave a Comment

Is Glucometrics The Missing Data in the Fight Against COVID-19?

Glucometrics – the system-wide analysis of inpatient glucose data – should be of fundamental interest for hospital administrators striving to improve the outcomes of their patients. Why is this data so important? Proper glycemic control has been linked to improved outcomes and decreased length of stay time and time again across a myriad of conditions – whether it’s someone recuperating from a heart attack, battling pneumonia, or recovering from surgery. The U.S. health system lacks
Read More

Why Remote Medical Solutions Are More Than Just A Pandemic Response

by Eran Atlas, Co-Founder & CEO of DreaMed Diabetes 09/16/2020 Leave a Comment

Why remote medical solutions are more than just a pandemic response

The health industry has increasingly emphasized convenience these past few decades, with methods developed to seamlessly integrate health management into our daily routines. Gone are the days in which people needed an entire day off just to see the doctor. This same focus has taken on extra meaning as of late, with the pandemic creating a need for treatment options that work around the constraints of social distancing. As a result, a host of digital-based solutions began appearing, providing
Read More

FDA Approves Medtronic’s Insulin Pump System for People with Type 1 Diabetes

by Jasmine Pennic 09/02/2020 Leave a Comment

FDA Approves Medtronic’s Insulin Pump System for People with Type 1 Diabetes

What You Should Know: - Medtronic announced the U.S. Food and Drug Administration (FDA) approval of the MiniMed™ 770G hybrid insulin pump system with smartphone connectivity and an expanded age indication to patients with Type 1 diabetes aged 2 and up ― the lowest age indication by the FDA for an automated insulin pump system.  - The new MiniMed 770G system comes with the Guardian™ Sensor 34, the MiniMed™ Mobile app (compatible with both iPhone and Android), and Roche Accu-Chek®
Read More

Medtronic Acquires Smart Insulin Pen Company Companion Medical

by Fred Pennic 08/11/2020 Leave a Comment

Medtronic Acquires Smart Insulin Pen Company Companion Medical

What You Should Know: - Today, Medtronic announced that it will acquire Companion Medical, the manufacturer of InPen, a smart insulin pen system paired with an integrated diabetes management app. - The addition of Companion’s InPen system builds upon Medtronic's strategic acquisitions of Nutrino and Klue to further improve overall automated decision-making capabilities and optimizes dosing decisions using algorithms and AI for patients. Medtronic, today announced the
Read More

DreaMed Diabetes Supports Research on Efficacy of Virtual Diabetes Care

by Fred Pennic 08/10/2020 Leave a Comment

diabetes management qualcomm medtronic diabetes

What You Should Know: - DreaMed Diabetes, the developer of personalized, AI-based diabetes management solutions, will participate in a clinical study, led by Jaeb Center for Health Research Foundation, to evaluate the efficacy of virtual treatment for diabetes patients. The research is funded by a grant from The Leona M. and Harry B. Helmsley Charitable Trust.  - DreaMed uses AI-powered technology to seamlessly treat patients remotely with its virtual diabetes management service by
Read More

5 Reasons Why Providers Need Electronic Support for Glycemic Management

by Robby Booth, SVP of Research and Development at Glytec 06/16/2020 Leave a Comment

It’s no secret hyperglycemia and hypoglycemia are associated with adverse outcomes in hospitalized patients. We’ve known for many years that hyperglycemia is widespread in the hospital, causes immune dysfunction, higher rates of infection, a longer length of hospital stay, complications, and even death.  Insulin has been the most effective therapy for hyperglycemia since it was first created almost 100 years ago, but it can also be dangerous if not managed properly. In fact, nearly 50% of all
Read More

Big Data Takes on the Silent Epidemic of Undiagnosed Behavioral Health Conditions

by Jeremiah Stone, Chief Technology Officer, Catasys 06/05/2020 Leave a Comment

Big Data Takes on the Silent Epidemic of Undiagnosed Behavioral Health

Prior to the COVID-19 pandemic, a study found that almost half of Americans will experience an episode of mental illness in their lives, but may never get the diagnosis and treatment they need. In a more recent finding, over 25% of American adults now meet the criteria for a diagnosis of severe mental distress.  The looming impact on our collective mental health is concerning enough, but there are also serious implications for physical health. Left unaddressed, behavioral health issues
Read More

Welldoc Awarded 8th FDA Clearance for Bluestar Medical Device for Diabetes

by Jasmine Pennic 06/04/2020 Leave a Comment

Welldoc’s BlueStar Integration with Xealth Improves Patient Engagement by 2.5X

What You Should Know: Marks 8th FDA clearance for BlueStar, the only reimbursable software as a medical device for diabetes that integrates with all of a patient's existing devices. Welldoc, revolutionizing digital health with the first FDA-cleared Software as a Medical Device (SaMD) for diabetes, announced today that the U.S. Food and Drug Administration (FDA) has cleared an additional feature for the digital health product BlueStar Rx which supports individuals using long-acting
Read More

Non-Invasive Technology for Measuring & Monitoring Liver Fat

by Scott Howell, D.O., MPH&TM, CPE, Advisor to Echosens 05/27/2020 Leave a Comment

As part of the growing awareness about chronic disease, it’s important to understand the relationship between nonalcoholic fatty liver disease (NAFLD), an asymptomatic condition characterized by elevated levels of fat in the liver, and diabetes. As a common complication of Type 2 diabetes and obesity, NAFLD can be overlooked comorbidity. Diabetes is one of the leading causes of disability and death in the United States. One in 10 Americans have diabetes – more than 30 million people – and
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to page 5
  • Go to page 6
  • Go to page 7
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |